Author profile
Jeffrey Eppler, MD
I was pleased to see the BCMJ publish Dr Mark Elliott’s piece, “The age of mushrooms is upon us in medicine.” Psychedelics such as LSD and psilocybin showed great promise as investigational tools and, in the case of LSD... Read More
I read Drs Mazowita and Kozak’s article “First do no harm: Reflections on the application of consensus guidelines for diabetes and other chronic conditions in residential care” [BCMJ 2013;55:80-84] with great... Read More
I feel compelled to take issue with the points that Dr Ray Baker raises in his opinion piece “More reefer madness” [BCMJ 2001;43(6):362]. Dr Baker speaks of a “cannabinoid antagonist” that “when administered to rats... Read More